XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Note 5 - Securities -
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]

Note 5 Securities

 

The amortized cost and fair values of securities available for sale as of June 30, 2023, and December 31, 2022 are summarized as follows:

 

  

June 30, 2023

 
  

(Dollars in thousands)

 
      

Gross

  

Gross

     
  

Amortized

  

Unrealized

  

Unrealized

  

Fair

 
  

Cost

  

Gains

  

Losses

  

Value

 

U.S. Treasury Securities

 $32,731  $-  $2,508  $30,223 

U.S. Government Agencies

  50,253   -   2,821   47,432 

Corporate Securities

  49,383   -   6,559   42,824 

Mortgage-Backed Securities

  501,470   38   57,472   444,036 

Municipal Securities

  346,333   37   33,111   313,259 

Total Securities Available for Sale

 $980,170  $75  $102,471  $877,774 

 

  

December 31, 2022

 
  

(Dollars in thousands)

 
      

Gross

  

Gross

     
  

Amortized

  

Unrealized

  

Unrealized

  

Fair

 
  

Cost

  

Gains

  

Losses

  

Value

 

U.S. Treasury Securities

 $32,783  $-  $2,668  $30,115 

U.S. Government Agencies

  50,288   -   2,916   47,372 

Corporate Securities

  48,475   25   2,496   46,004 

Mortgage-Backed Securities

  506,671   267   55,213   451,725 

Municipal Securities

  347,382   11   31,858   315,535 

Total Securities Available for Sale

 $985,599  $303  $95,151  $890,751 

 

The following tables present a summary of securities with gross unrealized losses and fair values at June 30, 2023 and December 31, 2022, aggregated by investment category and length of time in a continued unrealized loss position. 

 

  June 30, 2023 
  Less Than 12 Months  12 Months or Greater  Total 
  (Dollars in thousands) 
      

Gross

      

Gross

      

Gross

 
  

Fair

  

Unrealized

  

Fair

  

Unrealized

  

Fair

  

Unrealized

 
  

Value

  

Losses

  

Value

  

Losses

  

Value

  

Losses

 

U.S. Treasury Securities

 $-  $-  $30,223  $2,508  $30,223  $2,508 

U.S. Government Agencies

  -   -   47,432   2,821   47,432   2,821 

Corporate Securities

  26,587   3,791   16,237   2,768   42,824   6,559 

Mortgage-Backed Securities

  41,314   1,597   391,178   55,875   432,492   57,472 

Municipal Securities

  49,608   3,201   251,202   29,910   300,810   33,111 

Total Securities Available for Sale

 $117,509  $8,589  $736,272  $93,882  $853,781  $102,471 

 

  

December 31, 2022

 
  

Less Than 12 Months

  

12 Months or Greater

  

Total

 
  

(Dollars in thousands)

 
      

Gross

      

Gross

      

Gross

 
  

Fair

  

Unrealized

  

Fair

  

Unrealized

  

Fair

  

Unrealized

 
  

Value

  

Losses

  

Value

  

Losses

  

Value

  

Losses

 

U.S. Treasury Securities

 $9,702  $374  $20,413  $2,294  $30,115  $2,668 

U.S. Government Agencies

  24,405   595   22,967   2,321   47,372   2,916 

Corporate Securities

  19,564   1,359   6,385   1,137   25,949   2,496 

Mortgage-Backed Securities

  115,692   7,473   324,043   47,740   439,735   55,213 

Municipal Securities

  143,035   10,206   131,944   21,652   274,979   31,858 

Total Securities Available for Sale

 $312,398  $20,007  $505,752  $75,144  $818,150  $95,151 

 

As of June 30, 2023, no allowance for credit losses was recognized on available for sale securities in an unrealized loss position as management does not believe any of the securities are impaired due to credit quality.  This determination is based on the Company’s analysis of the underlying risk characteristics including credit ratings, historical loss experience, and other qualitative factors. Further, the securities continue to make principal and interest payments under their contractual terms and management does not have the intent to sell any of the securities and believes that it is more likely than not that the Company will not have to sell any such securities before a recovery of amortized cost basis.  Therefore, the Company has determined the unrealized losses are due to changes in market interest rates compared to rates when the securities were acquired.

 

For the period ended December 31, 2022, management evaluated securities for other than temporary impairment.  Consideration was given to the extent and length of time the fair value had been below cost, the reasons for the decline in value, and the Company’s intent to sell a security or whether it was more likely than not that the Company would be required to sell the security before the recovery of its amortized cost.  The Company utilized a process to identify securities that could potentially have a credit impairment that was other than temporary.  The process involved evaluating each security for impairment by monitoring credit performance, collateral type, collateral geography, loan-to-value ratios, credit scores, loss severity levels, pricing levels, downgrades by rating agencies, cash flow projections and other factors as indicators of potential credit issues.  The Company determined no other than temporary impairment existed at December 31, 2022.

 

The amortized cost and fair values of securities available for sale as of June 30, 2023, by contractual maturity are shown below.  Actual maturities may differ from contractual maturities in mortgage-backed securities because the mortgages underlying the securities may be called or repaid without any penalties. 

 

  

Amortized

  

Fair

 
  

Cost

  

Value

 
  

(Dollars in thousands)

 

Less Than One Year

 $28,306  $27,764 

One to Five Years

  235,160   217,886 

Over Five to Ten Years

  363,195   323,256 

Over Ten Years

  353,509   308,868 

Total Securities Available for Sale

 $980,170  $877,774 

 

At June 30, 2023, the Company had pledged securities with a fair value of $386.3 million against our public deposit and repurchase agreements, and $394.6 million against our Bank Term Funding Program facility.

 

At June 30, 2023 and December 31, 2022, accrued interest receivable on securities was $4.6 million and $4.4 million, respectively, and included within accrued interest receivable on the consolidated balance sheets.